Today’s clinical trials are becoming more complex, trending towards patient-centric approaches and biomarker-driven designs
Higher burdens are put on sites and patients to adhere to the protocols
We present a comprehensive site support model that reduces burdens on investigators, site clinical research staff and patients, increasing protocol compliance and data quality.
Overcoming financial constraints when budgets are limited and resources tight
Fierce site competition: How start-ups can compete with established companies for sites
Utilizing effective planning to improve study and program efficiency without compromising patient safety
Agile and adaptable: Being prepared to adjust your strategy and approach as needed
Understand what often goes unseen in site networks, including turnover, burnout, and uneven site support, and how these issues impact delivery
Learn how to evaluate CRO and network partners beyond surface-level metrics like site count and start-up timelines
Explore why sustainable site relationships depend on consistency, communication, and shared goals rather than financial incentives alone
Hear real-world insights into the operational strain sites face and how sponsors can better align with what sites truly need to succeed
Gain a more realistic, strategic framework for assessing site networks before outsourcing decisions are made
How do we look at data transparency issues when scaling AI?
Case study on AI rights and a look at recently released survey discussing where things need to change
Without GDPR, what can be done to protect patients regarding data sovereignty?
Delving into the unique and amplified challenges for AI risk assessment
How can we effectively leverage AI in our heavily regulated environment?
Current biotech funding and pipeline trends shaping early and late phase development
How market dynamics are influencing trial initiation and program design in 2025
Shifts in CRO selection and strategic approaches among emerging biotechs
Discuss methods for identifying and engaging the right patient population
Learn strategies for reducing barriers to participation
Focus on enhancing site and investigator engagement training, tools, and incentives
Building trust – communication and transparency takeaways
Includes clear, relatable examples of how AI is practically applied within healthcare and pharma, empowering executives without deep technical backgrounds
Posts navigation
